About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Genomic Risk in Retroperitoneal Sarcoma | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT06436846

Genomic Risk in Retroperitoneal Sarcoma

The protocol intends to explore the biology which may underlie recurrences of retroperitoneal liposarcoma. Surgery remains the only curative intent intervention for this disease. Often, tumors recur i...

Lead sponsor: Fox Chase Cancer Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Anthony Villano, MD

CONTACT

215-728-3686 [email protected]

Sponsors

Lead Sponsor

Fox Chase Cancer Center

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Adult patients (age ≥18 years).
•Histologically confirmed retroperitoneal liposarcoma via preoperative biopsy, or cross-sectional imaging suspicious for liposarcoma with planned surgical resection
•Will be undergoing surgical resection for treatment of primary or recurrent disease
•Have provided informed consent to participate in this study

Exclusion Criteria

•Prior surgical anatomy which makes sampling of remote areas of the retroperitoneum technically impossible or clinically undesirable for safety reasons

Related studies

RECRUITINGPhase 1/2

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

NCT06498648 · Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, and more

RECRUITINGPhase 3

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT06422806 · Metastatic Dedifferentiated Liposarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, and more

RECRUITINGPhase 2

Agnostic Therapy in Rare Solid Tumors

NCT06638931 · Urachal Cancer, Parathyroid Carcinoma, and more

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298 · Breast Cancer, NOS, CNS Primary Tumor, NOS, and more

RECRUITINGPhase 2

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma

NCT06905132 · Soft Tissue Sarcoma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 31, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment50

Start dateMar 2022

Last updatedMay 31, 2024

Condition

Retroperitoneal Liposarcoma Soft Tissue Sarcoma

Locations shown

Fox Chase Cancer Center

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 31, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions